98 related articles for article (PubMed ID: 9269868)
1. Factors affecting the in vitro release of recombinant human interferon-gamma (rhIFN-gamma) from PLGA microspheres.
Yang J; Cleland JL
J Pharm Sci; 1997 Aug; 86(8):908-14. PubMed ID: 9269868
[TBL] [Abstract][Full Text] [Related]
2. Stable formulations of recombinant human growth hormone and interferon-gamma for microencapsulation in biodegradable microspheres.
Cleland JL; Jones AJ
Pharm Res; 1996 Oct; 13(10):1464-75. PubMed ID: 8899836
[TBL] [Abstract][Full Text] [Related]
3. The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres.
Cleland JL; Mac A; Boyd B; Yang J; Duenas ET; Yeung D; Brooks D; Hsu C; Chu H; Mukku V; Jones AJ
Pharm Res; 1997 Apr; 14(4):420-5. PubMed ID: 9144725
[TBL] [Abstract][Full Text] [Related]
4. Microencapsulation of protein drugs for drug delivery: strategy, preparation, and applications.
Ma G
J Control Release; 2014 Nov; 193():324-40. PubMed ID: 25218676
[TBL] [Abstract][Full Text] [Related]
5. Insulin loaded PLGA microspheres: effect of zinc salts on encapsulation, release, and stability.
Manoharan C; Singh J
J Pharm Sci; 2009 Feb; 98(2):529-42. PubMed ID: 18548615
[TBL] [Abstract][Full Text] [Related]
6. Stability of bovine serum albumin complexed with PEG-poly(L-histidine) diblock copolymer in PLGA microspheres.
Kim JH; Taluja A; Knutson K; Han Bae Y
J Control Release; 2005 Dec; 109(1-3):86-100. PubMed ID: 16266769
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of recombinant human growth hormone against emulsification-induced aggregation by Pluronic surfactants during microencapsulation.
Wei G; Lu LF; Lu WY
Int J Pharm; 2007 Jun; 338(1-2):125-32. PubMed ID: 17336005
[TBL] [Abstract][Full Text] [Related]
8. Preservation of biological activity of glial cell line-derived neurotrophic factor (GDNF) after microencapsulation and sterilization by gamma irradiation.
Checa-Casalengua P; Jiang C; Bravo-Osuna I; Tucker BA; Molina-Martínez IT; Young MJ; Herrero-Vanrell R
Int J Pharm; 2012 Oct; 436(1-2):545-54. PubMed ID: 22828071
[TBL] [Abstract][Full Text] [Related]
9. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
He JT; Tao XM; Mo W; Song HY
Yao Xue Xue Bao; 2006 Jan; 41(1):12-8. PubMed ID: 16683521
[TBL] [Abstract][Full Text] [Related]
11. Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres.
Duggirala SS; Mehta RC; DeLuca PP
Pharm Dev Technol; 1996 Apr; 1(1):11-9. PubMed ID: 9552326
[TBL] [Abstract][Full Text] [Related]
12. Sustained release of bioactive glycosylated glial cell-line derived neurotrophic factor from biodegradable polymeric microspheres.
Garbayo E; Ansorena E; Lanciego JL; Aymerich MS; Blanco-Prieto MJ
Eur J Pharm Biopharm; 2008 Aug; 69(3):844-51. PubMed ID: 18417331
[TBL] [Abstract][Full Text] [Related]
13. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
14. Production, purification, and chemical stability of recombinant human interferon-γ in low oxygen tension condition: a formulation approach.
Malek-Sabet N; Masoumian MR; Zeinali M; Khalilzadeh R; Mousaabadi JM
Prep Biochem Biotechnol; 2013; 43(6):586-600. PubMed ID: 23742090
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
16. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
Jaganathan KS; Vyas SP
Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
[TBL] [Abstract][Full Text] [Related]
17. Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer.
He J; Feng M; Zhou X; Ma S; Jiang Y; Wang Y; Zhang H
Int J Pharm; 2011 Sep; 416(1):69-76. PubMed ID: 21699969
[TBL] [Abstract][Full Text] [Related]
18. Stabilization of recombinant interferon-alpha by pegylation for encapsulation in PLGA microspheres.
Diwan M; Park TG
Int J Pharm; 2003 Feb; 252(1-2):111-22. PubMed ID: 12550786
[TBL] [Abstract][Full Text] [Related]
19. Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds.
Jaklenec A; Hinckfuss A; Bilgen B; Ciombor DM; Aaron R; Mathiowitz E
Biomaterials; 2008 Apr; 29(10):1518-25. PubMed ID: 18166223
[TBL] [Abstract][Full Text] [Related]
20. Formulation and in vitro/in vivo evaluation of terbutaline sulphate incorporated in PLGA (25/75) and L-PLA microspheres.
Selek H; Sahin S; Ercan MT; Sargon M; Hincal AA; Kas HS
J Microencapsul; 2003; 20(2):261-71. PubMed ID: 12554379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
